| RS1131691867 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691868 |
PEX7
|
Health Risk |
Likely pathogenic |
— |
| RS1131691869 |
CENPE
|
Health Risk |
Likely pathogenic |
— |
| RS1131691870 |
GRIN1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691871 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691872 |
EIF2B2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691873 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1131691874 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1131691875 |
GABRB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS1131691876 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691877 |
DNM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizure, Seizure |
| RS1131691878 |
KAT6A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691882 |
ELANE
|
Health Risk |
Likely pathogenic |
ELANE-related disorder, ELANE-related disorder |
| RS1131691883 |
PNKP
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 12 |
| RS1131691884 |
GABRA1
|
Health Risk |
Pathogenic |
— |
| RS1131691887 |
IQSEC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, X-linked 1 |
| RS1131691888 |
COL1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691889 |
OFD1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 10, Joubert syndrome 10 |
| RS1131691890 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS1131691892 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS1131691893 |
CHRNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal multiple pterygium syndrome, Congenital myasthenic syndrome 1A |
| RS1131691894 |
SURF1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 4K, Mitochondrial complex IV deficiency |
| RS1131691895 |
TUBB3
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 1, Brain malformation |
| RS1131691896 |
FLI1
|
Health Risk |
Likely pathogenic |
Bleeding disorder, platelet-type |
| RS1131691899 |
ATP2A2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691900 |
L1CAM
|
Health Risk |
Likely pathogenic |
— |
| RS1131691901 |
KRT6B
|
Health Risk |
Likely pathogenic |
— |
| RS1131691902 |
SLC19A3
|
Health Risk |
Likely pathogenic |
— |
| RS1131691903 |
VPS45
|
Health Risk |
Likely pathogenic |
— |
| RS1131691904 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
DPAGT1-congenital disorder of glycosylation, DPAGT1-congenital disorder of glycosylation |
| RS1131691909 |
DYRK1A
|
Health Risk |
Likely pathogenic |
— |
| RS1131691910 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1131691911 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1131691912 |
ZEB2
|
Health Risk |
Pathogenic |
— |
| RS1131691916 |
ABCD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Adrenoleukodystrophy, Inborn genetic diseases |
| RS1131691917 |
SPTLC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory and autonomic |
| RS1131691919 |
ITPR1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS1131691921 |
NR3C2
|
Health Risk |
Pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, Pseudohyperaldosteronism type 2 |
| RS1131691924 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Rare genetic deafness, Retinal dystrophy |
| RS1131691925 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1131691926 |
CDKL5
|
Health Risk |
Pathogenic |
— |
| RS1131691927 |
SCN2A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS1131691928 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691929 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 2 with or without anosmia, Pfeiffer syndrome |
| RS1131691931 |
ENG
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary hemorrhagic telangiectasia |
| RS1131691932 |
TBX5
|
Health Risk |
Likely pathogenic |
— |
| RS1131691933 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1131691935 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontometaphyseal dysplasia, Melnick-Needles syndrome |
| RS1131691936 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS1131691937 |
STAT3
|
Health Risk |
Likely pathogenic |
Hyper-IgE recurrent infection syndrome 1, autosomal dominant |
| RS1131691938 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691939 |
KCNA2
|
Health Risk |
Pathogenic |
— |
| RS1131691940 |
ATP1A3
|
Health Risk |
Likely pathogenic |
Alternating hemiplegia of childhood 2, Alternating hemiplegia of childhood 2 |
| RS1131691944 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1131691946 |
DYRK1A
|
Health Risk |
Pathogenic |
Complex neurodevelopmental disorder, Complex neurodevelopmental disorder |
| RS1131691949 |
ZFYVE26
|
Health Risk |
Pathogenic |
— |
| RS1131691951 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial infantile |
| RS1131691952 |
PDHA1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691954 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1131691955 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1131691957 |
CHRNB1
|
Health Risk |
Pathogenic |
— |
| RS1131691958 |
KIF7
|
Health Risk |
Pathogenic |
— |
| RS1131691960 |
SHANK3
|
Health Risk |
Pathogenic |
— |
| RS1131691963 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS1131691964 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS1131691965 |
TSC2
|
Health Risk |
Likely pathogenic |
Lymphangiomyomatosis, Isolated focal cortical dysplasia type II |
| RS1131691966 |
SHH
|
Health Risk |
Likely pathogenic |
— |
| RS1131691967 |
NIPBL
|
Health Risk |
Likely pathogenic |
— |
| RS1131691968 |
SPG7
|
Health Risk |
Likely pathogenic |
— |
| RS1131691969 |
SLC52A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1131691970 |
GLUL
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 16 |
| RS1131691971 |
SPAST
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 4, SPAST-related disorder |
| RS1131691972 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1131691973 |
SLC35A2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691974 |
KCNA2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691975 |
GSS
|
Health Risk |
Likely pathogenic |
— |
| RS1131691976 |
ALDH7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyridoxine-dependent epilepsy, Pyridoxine-dependent epilepsy |
| RS1131691977 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1131691978 |
SMARCA2
|
Health Risk |
Likely pathogenic |
— |
| RS1131691979 |
SYNGAP1
|
Health Risk |
Pathogenic |
Infantile epilepsy syndrome, Inborn genetic diseases |
| RS1131691980 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1131691981 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1131691982 |
TAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS1131691983 |
AIFM1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691986 |
RAPSN
|
Health Risk |
Pathogenic |
Hydrops fetalis, Congenital myasthenic syndrome |
| RS1131691988 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1131691989 |
SHH
|
Health Risk |
Likely pathogenic |
Solitary median maxillary central incisor syndrome, SHH-related disorder |
| RS1131691992 |
CYP11B1
|
Health Risk |
Likely pathogenic |
— |
| RS1131691994 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1131691996 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1131691997 |
HRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Costello syndrome, Costello syndrome |
| RS1131691999 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Uterine corpus endometrial carcinoma, Uterine corpus endometrial carcinoma |
| RS1131692000 |
PRRT2
|
Health Risk |
Likely pathogenic |
— |
| RS1131692002 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1131692012 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1131692014 |
CHD2
|
Health Risk |
Pathogenic |
— |
| RS1131692017 |
HIBCH
|
Health Risk |
Pathogenic/Likely pathogenic |
3-hydroxyisobutyryl-CoA hydrolase deficiency, 3-hydroxyisobutyryl-CoA hydrolase deficiency |
| RS1131692019 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1131692020 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1131692022 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |